MarketFriction

Artemis Global Life Sciences Ltd((Merged)

NSE AGLSL · BSE 540616
₹49.45 -3.23%
NSE close2019-10-23
Market cap₹327 Cr.
P/E15.6
Merged or delisted Delivery 34.7%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales119.30126.22120.16137.33126.43140.89139.04140.16135.71
Expenses108.81113.88109.63111.76114.71123.82121.92122.25120.91
Operating Profit10.4912.3410.5325.5711.7217.0717.1217.9114.80
OPM %8.79%9.78%8.76%18.62%9.27%12.12%12.31%12.78%10.91%
Other Income1.131.280.901.061.170.890.631.310.59
Interest2.072.622.142.592.032.993.102.883.28
Depreciation4.354.944.774.744.904.965.025.205.45
Profit before tax5.206.064.5219.305.9610.019.6311.146.66
Tax %37.69%38.61%27.21%17.20%38.59%36.56%49.01%50.90%35.89%
Net Profit3.243.733.3015.973.656.354.915.474.27
EPS in Rs0.490.560.502.410.550.960.740.830.65
Mar 2017Mar 2018Mar 2019TTM
Sales463503547556
Expenses411443481489
Operating Profit52606667
OPM %11%12%12%12%
Other Income5323
Interest991112
Depreciation15192021
Profit before tax33353737
Tax %17%25%45%
Net Profit27262021
EPS in Rs4.103.973.103.18
Dividend Payout %0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%9%
Compounded Profit Growth%%%-21%
Stock Price CAGR%%%%
Return on Equity%%10%8%
Mar 2017Mar 2018Mar 2019
Equity Capital131313
Reserves234260280
Borrowings949176
Other Liabilities129133185
Total Liabilities469497554
Fixed Assets326352381
CWIP274349
Investments000
Other Assets116102124
Total Assets469497554
Mar 2017Mar 2018Mar 2019
Cash from Operating Activity527140
Cash from Investing Activity-70-67-50
Cash from Financing Activity22-1014
Net Cash Flow4-55
Free Cash Flow-1910-17
CFO/OP103%121%76%
Mar 2017Mar 2018Mar 2019
Debtor Days484052
Inventory Days
Days Payable
Cash Conversion Cycle484052
Working Capital Days-24-26-36
ROCE %13%14%
Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
Promoters69.82%69.82%69.82%69.82%69.82%69.82%69.82%69.82%69.82%69.82%
FIIs0.09%0.00%0.00%0.01%0.00%0.00%0.00%0.00%0.00%0.00%
DIIs0.91%0.91%0.91%0.91%0.91%0.92%0.95%1.17%1.17%1.22%
Government2.27%2.27%7.37%7.37%7.37%7.37%7.37%7.37%7.37%7.37%
Public26.91%27.00%21.90%21.89%21.90%21.89%21.86%21.64%21.64%21.59%
No. of Shareholders7,2417,0656,7696,4676,4266,3236,2426,2566,1806,110

Fundamentals

Market Cap₹ 327 Cr.
Current Price₹ 49.4
Stock P/E15.6
Book Value₹ 44.3
ROCE13.6 %
ROE7.65 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)9%
Compounded Profit Growth (TTM)-21%
Consolidated figures.
Ownership
Promoter holding69.82% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
PeriodAGLSLNifty 50Difference
1 week-1.5%-2.8% +1.3 pts
1 month+4.8%-6.8% +11.6 pts
3 months-3.8%-7.6% +3.8 pts
6 months-15.3%+0.4% -15.7 pts
1 year-34.1%-9.9% -24.1 pts
2 years-59.7%-13.6% -46.2 pts

Red flags

No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2019
Sales ₹136 Cr +7.3% vs Jun 2018. Net profit ₹4 Cr +17.0%.

Activity

Compare
No listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Artemis Global Life Sciences Ltd((Merged)?

Artemis Global Life Sciences Ltd((Merged) (AGLSL) has a market capitalisation of Rs 327 Cr. at the 2019-10-23 close.

What is the P/E ratio of Artemis Global Life Sciences Ltd((Merged)?

Artemis Global Life Sciences Ltd((Merged) trades at a P/E of 15.6 on trailing twelve-month profit, at the 2019-10-23 close.

What were Artemis Global Life Sciences Ltd((Merged)'s latest quarterly results?

In the Jun 2019 quarter, Artemis Global Life Sciences Ltd((Merged) sales was Rs 136 Cr (+7.3% vs Jun 2018) and net profit was Rs 4 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03